Worth Venture Partners, LLC Spruce Biosciences, Inc. Transaction History

Worth Venture Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.04 - $2.93 $233,853 - $658,836	224,859 Added 74.44%	526,933 $1.54 Million
Q3 2023 Nov 14, 2023	BUY	$2.04 - $2.54 $49,878 - $62,103	24,450 Added 8.81%	302,074 $682,000
Q2 2023 Aug 14, 2023	BUY	$1.92 - $2.6 $13,440 - $18,200	7,000 Added 2.59%	277,624 $596,000
Q1 2023 May 15, 2023	BUY	$1.15 - $3.17 $311,217 - $857,878	270,624 New	270,624 $598,000

16.9M

26.9K

59.3K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $10.4M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.